237 related articles for article (PubMed ID: 12526791)
1. Parc: a cytoplasmic anchor for p53.
Nikolaev AY; Li M; Puskas N; Qin J; Gu W
Cell; 2003 Jan; 112(1):29-40. PubMed ID: 12526791
[TBL] [Abstract][Full Text] [Related]
2. Parc-ing p53 in the cytoplasm.
Kastan MB; Zambetti GP
Cell; 2003 Jan; 112(1):1-2. PubMed ID: 12526785
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.
Andrews P; He YJ; Xiong Y
Oncogene; 2006 Aug; 25(33):4534-48. PubMed ID: 16547496
[TBL] [Abstract][Full Text] [Related]
4. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
[TBL] [Abstract][Full Text] [Related]
5. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S
Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation.
Yamamoto H; Ozaki T; Nakanishi M; Kikuchi H; Yoshida K; Horie H; Kuwano H; Nakagawara A
Genes Cells; 2007 Apr; 12(4):461-71. PubMed ID: 17397394
[TBL] [Abstract][Full Text] [Related]
8. Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.
Dowell JD; Tsai SC; Dias-Santagata DC; Nakajima H; Wang Z; Zhu W; Field LJ
Biochim Biophys Acta; 2007 Mar; 1773(3):358-66. PubMed ID: 17229476
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.
Pei XH; Bai F; Li Z; Smith MD; Whitewolf G; Jin R; Xiong Y
Cancer Res; 2011 Apr; 71(8):2969-77. PubMed ID: 21487039
[TBL] [Abstract][Full Text] [Related]
10. Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis.
Zhao LY; Liao D
J Virol; 2003 Dec; 77(24):13171-81. PubMed ID: 14645574
[TBL] [Abstract][Full Text] [Related]
11. p53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts.
Mulhall JP; Barnas J; Kobylarz K; Mueller A
BJU Int; 2010 Dec; 106(11):1706-13. PubMed ID: 21078039
[TBL] [Abstract][Full Text] [Related]
12. A novel p53-binding domain in CUL7.
Kasper JS; Arai T; DeCaprio JA
Biochem Biophys Res Commun; 2006 Sep; 348(1):132-8. PubMed ID: 16875676
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.
Cai X; Liu X
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16958-63. PubMed ID: 18952844
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
15. The importance of p53 location: nuclear or cytoplasmic zip code?
O'Brate A; Giannakakou P
Drug Resist Updat; 2003 Dec; 6(6):313-22. PubMed ID: 14744495
[TBL] [Abstract][Full Text] [Related]
16. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.
Rodriguez-Lopez AM; Xenaki D; Eden TO; Hickman JA; Chresta CM
Mol Pharmacol; 2001 Jan; 59(1):135-43. PubMed ID: 11125034
[TBL] [Abstract][Full Text] [Related]
17. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
18. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
Honda R; Tanaka H; Yasuda H
FEBS Lett; 1997 Dec; 420(1):25-7. PubMed ID: 9450543
[TBL] [Abstract][Full Text] [Related]
20. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.
Sengupta S; Vonesch JL; Waltzinger C; Zheng H; Wasylyk B
EMBO J; 2000 Nov; 19(22):6051-64. PubMed ID: 11080152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
